Cargando…
Serotonin 5-HT(2A) receptor activity mediates adipocyte differentiation through control of adipogenic gene expression
Serotonin 5-HT(2) receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT(2A) receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues. We have found that 5-HT(2A) receptor antagonists inhibit h...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492876/ https://www.ncbi.nlm.nih.gov/pubmed/34611182 http://dx.doi.org/10.1038/s41598-021-98970-1 |
Sumario: | Serotonin 5-HT(2) receptors are expressed in many tissues and play important roles in biological processes. Although the 5-HT(2A) receptor is primarily known for its role in central nervous system, it is also expressed in peripheral tissues. We have found that 5-HT(2A) receptor antagonists inhibit human subcutaneous primary adipocyte differentiation. We also show that siRNA knockdown of the 5-HT(2A) receptor blocks differentiation. Using gene expression analysis in combination with receptor antagonists we found that activity of 5-HT(2A) receptors is necessary very early in the differentiation process to mediate expression of adipogenic genes, including peroxisome proliferator-activated receptor gamma (ppar-γ), adipocyte protein 2 (aP2), adiponectin, and serine/threonine-protein kinase 1 (sgk1). We show here for the first time that 5-HT(2A) receptor activity is necessary for differentiation of human primary subcutaneous preadipocytes to adipocytes, and that 5-HT(2A) receptor activity mediates key genes related to adipogenesis during this process. Importantly, this work contributes to a greater understanding of the adipocyte differentiation process, as well as to the role of 5-HT(2A) receptors in peripheral tissues, and may be relevant to the development of novel therapeutic strategies targeting this receptor for the treatment of obesity related diseases. |
---|